GS
75
-4
DE
36
-2
CMG
69
-3
AON
60
2
DRI
56
2
EFX
41
-2
SE
60
-5
VNO
60
8
IVZ
49
-3
GILD
56
-4
URBN
66
2
INTC
49
16
VLO
42
2
HCP
70
-4
AA
38
-2
T
48
3
FLS
76
-2
PSA
58
5
GOOGL
59
-8
CVX
38
6
GS
75
-4
DE
36
-2
CMG
69
-3
AON
60
2
DRI
56
2
EFX
41
-2
SE
60
-5
VNO
60
8
IVZ
49
-3
GILD
56
-4
URBN
66
2
INTC
49
16
VLO
42
2
HCP
70
-4
AA
38
-2
T
48
3
FLS
76
-2
PSA
58
5
GOOGL
59
-8
CVX
38
6
Financhill
Back

Credit Suisse Asset Mgmt Income Fund Vs. Dyne Therapeutics Industry Stock Comparison

Sell
35

CIK
Credit Suisse Asset Mgmt Income Fund

Last Price:
2.98
Seasonality Move:
1.79%
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
35
Credit Suisse Asset Mgmt Income Fund (CIK) is a Sell

Is Credit Suisse Asset Mgmt Income Fund a Buy, Sell or Hold?

  • The current Credit Suisse Asset Mgmt Income Fund [CIK] share price is $2.99. The Score for CIK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CIK Stock Price Chart

What is Credit Suisse Asset Mgmt Income Fund's stock price today?

  • The Credit Suisse Asset Mgmt Income Fund share price today is $2.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CIK is experiencing slight buying pressure.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $34.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 46.39 Sell
Chaikin Money Flow: 244506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.97 - 3.05) Sell
Bollinger Bands (100): (2.99 - 3.09) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 60.64 Buy
Chaikin Money Flow: 1192325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.99 - 33.51) Buy
Bollinger Bands (100): (31.49 - 42.59) Sell

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.97 Buy
20-day SMA: 2.99 Sell
50-day SMA: 3.04 Sell
200-day SMA: 3 Sell
8-day EMA: 2.98 Buy
20-day EMA: 3 Sell
50-day EMA: 3.02 Sell
200-day EMA: 2.99 Sell

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Buy
20-day SMA: 30.81 Buy
50-day SMA: 32.62 Buy
200-day SMA: 32.06 Buy
8-day EMA: 30.24 Buy
20-day EMA: 30.74 Buy
50-day EMA: 32.95 Buy
200-day EMA: 30.83 Buy

Credit Suisse Asset Mgmt Income Fund Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

Credit Suisse Asset Mgmt Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):